A candidate gene study of serotonergic pathway genes and pain relief during treatment with escitalopram in patients with neuropathic pain shows significant association to serotonin receptor2C (HTR2C)

No relationship between the ins del polymorphism of the serotonin transporter promoter and pain perception in fibromyalgia patients and healthy controls

(2010) Stéphane Potvin et al.   EUROPEAN JOURNAL OF PAIN

The evidence for pharmacological treatment of neuropathic pain

(2010) Nanna Brix Finnerup et al.   PAIN

Role of warfarin pharmacogenetic testing in clinical practice

(2010) Guang-Ming Tan et al.   PHARMACOGENOMICS

Hardy-Weinberg Equilibrium Testing of Biological Ascertainment for Mendelian Randomization Studies

(2009) Santiago Rodriguez et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Impact of CYP2C19 phenotypes on escitalopram metabolism and an evaluation of pupillometry as a serotonergic biomarker

(2009) L. Noehr-Jensen et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Progress in Genome-Wide Association Studies of Human Height

(2009) Joel N. Hirschhorn et al.   Hormone Research in Paediatrics

Genetic association studies to detect adverse drug reactions: abacavir hypersensitivity as an example

(2009) Arlene R Hughes et al.   PHARMACOGENOMICS

5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients

(2009) Masaki Kato et al.   PSYCHIATRY RESEARCH

Escitalopram in painful polyneuropathy: A randomized, placebo-controlled, cross-over trial

(2008) Marit Otto et al.   PAIN

ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder

(2007) Masaki Kato et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY